Log In
BCIQ
Print this Print this
 

CXB006

  Manage Alerts
Collapse Summary General Information
Company CeNeRx BioPharma Inc.
DescriptionCannabinoid CB1 receptor agonist
Molecular Target Cannabinoid CB1 receptor (CNR1)
Mechanism of ActionCannabinoid CB1 receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain associated with peripheral neuropathy, glaucoma and spasticity
Regulatory Designation
PartnerNeuroscienze PharmaNess s.c.a r.l.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today